Who is the CEO of Heartseed, Inc.?

The CEO of Heartseed, Inc. is Keiichi Fukuda FACC,.

What industry does Heartseed, Inc. belong to?

Heartseed, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector.

Where is Heartseed, Inc. headquartered?

Heartseed, Inc. is headquartered at 5th Floor, Seavans South Building, Tokyo, JP.

What is the IPO date of Heartseed, Inc.?

Heartseed, Inc. went public on July 30, 2024.

How many employees does Heartseed, Inc. have?

Heartseed, Inc. has approximately 39 full-time employees.

Heartseed, Inc.

219A.T•JPX

Healthcare

Medical - Pharmaceuticals

¥3550.00

¥25.00(0.71%)

Heartseed, Inc. (219A.T) Company Profile & Overview

Explore Heartseed, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Heartseed, Inc. (219A.T) Company Profile & Overview

Heartseed, Inc. engages in the provision of cardiac regenerative medicine. The company was founded by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa and Yutaro Kasai on November 30, 2015 and is headquartered in Tokyo, Japan.

SectorHealthcare

IndustryMedical - Pharmaceuticals

CEOKeiichi Fukuda FACC,

Contact Information

http://www.heartseed.jp

5th Floor, Seavans South Building, Tokyo

Company Facts

39 Employees

IPO DateJul 30, 2024

CountryJP

Actively Trading

Frequently Asked Questions

;